OraSure Technologies, Inc.
General ticker "OSUR" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $209.0M (TTM average)
OraSure Technologies, Inc. follows the US Stock Market performance with the rate: 50.4%.
Estimated limits based on current volatility of 1.7%: low 3.54$, high 3.67$
Factors to consider:
- Total employees count: 501 (-21.5%) as of 2024
- US accounted for 74.9% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Genomics market changes, Manufacturing scale up, Industry consolidation, R&D failure, Customer concentration
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.82$, 3.56$]
- 2026-12-31 to 2027-12-31 estimated range: [2.17$, 4.03$]
Financial Metrics affecting the OSUR estimates:
- Positive: with PPE of -2.7 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -0.03 <= 0.28
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Investing cash flow per share per price, % of 0 > -0.64
- Positive: -9.15 < Industry operating profit margin (median), % of -7.42
- Positive: Shareholder equity ratio, % of 84.54 > 63.63
Short-term OSUR quotes
Long-term OSUR plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $405.47MM | $185.83MM | $115.75MM |
| Operating Expenses | $372.79MM | $214.08MM | $187.72MM |
| Operating Income | $32.68MM | $-28.25MM | $-71.97MM |
| Non-Operating Income | $23.57MM | $12.25MM | $7.38MM |
| R&D Expense | $33.73MM | $26.05MM | $42.53MM |
| Income(Loss) | $56.26MM | $-16.00MM | $-64.59MM |
| Taxes | $2.60MM | $1.80MM | $1.80MM |
| Other Income(Loss) | $0.00MM | $-1.70MM | $-2.34MM |
| Net Income(Loss)* | $53.66MM | $-19.50MM | $-68.73MM |
| Stockholders Equity | $430.67MM | $410.34MM | $340.83MM |
| Inventory | $47.61MM | $34.20MM | $31.06MM |
| Assets | $482.85MM | $479.66MM | $403.17MM |
| Operating Cash Flow | $141.58MM | $27.37MM | $-0.05MM |
| Capital expenditure | $10.30MM | $3.80MM | $0.00MM |
| Investing Cash Flow | $66.15MM | $-39.03MM | $-0.01MM |
| Financing Cash Flow | $-3.02MM | $-4.18MM | $-0.02MM |
| Earnings Per Share** | $0.73 | $-0.26 | $-0.94 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.